Home / Healthcare / Alpha Thalassemia Treatment Market By Type Of Drugs (Folic Acid, Deferasirox, Deferiprone, Hydroxyurea) - Growth, Future Prospects And Competitive Landscape, 2019 – 2027

Alpha Thalassemia Treatment Market By Type Of Drugs (Folic Acid, Deferasirox, Deferiprone, Hydroxyurea) - Growth, Future Prospects And Competitive Landscape, 2019 – 2027

Published: Jun 2019 | Published By: Acute Market Reports

TABLE 1 Global Alpha Thalassemia Treatment (ATT) Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 2 North America ATT Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 3 North America ATT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 4 Europe ATT Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 5 Europe ATT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 6 Asia Pacific ATT Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 7 Asia Pacific ATT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 8 Latin America ATT Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 9 Latin America ATT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 10 Middle East & Africa ATT Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
TABLE 11 Middle East And Africa ATT Market, by Region, 2017 – 2027 (US$ Mn)
TABLE 12 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Bellicum Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Acceleron Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Merck & Co Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Alnylam Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Calimmune Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Editas Medicine Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Gilead Sciences Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +